Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 3Peptic Ulcer 2Gastritis 2Dyspepsia 2Stomach Ulcer 1Peptic Ulcer Hemorrhage 1Lymphoma, B-Cell, Marginal Zone 1Head and Neck Neoplasms 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1

Interventions

Bismuth 3Tetracycline 2Esomeprazole 2Clarithromycin 2Amoxicillin 2Surveys and Questionnaires 1Physical Examination 1Phlebotomy 1Minocycline 1Gastroscopy 1Furazolidone 1Endoscopy, Digestive System 11-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastritis × Esomeprazole × 1 year × Clear all
NCT07139366 2025-12-02

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Xijing Hospital of Digestive Diseases

Phase 4 Recruiting
1,248 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

NCT05742568 2025-07-03

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Xijing Hospital of Digestive Diseases

Phase 4 Completed
124 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡